← Open Payments lookup

ASHLEY ESHLEMAN: Open Payments

NPI 1851537187 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$435 in 20 payments from 12 companies in 2025. Trend: 2023 $139 · 2024 $310 · 2025 $435

Food & beverage: $435
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.6$138
Janssen Pharmaceuticals, Inc2$43
Vanda Pharmaceuticals Inc.1$36
Lundbeck LLC2$35
Otsuka America Pharmaceutical, Inc.2$34
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$26
ABBVIE INC.1$24
Tris Pharma Inc1$23
Collegium Pharmaceutical, Inc.1$23
E.R. Squibb & Sons, L.L.C.1$20

Products named: UZEDY, REXULTI, AUSTEDO XR, FANAPT, SPRAVATO, CAPLYTA, VRAYLAR, Dyanavel XR.

Industry payments across MD — which companies pay providers there.